X

Xencor

D
XNCR
USD
-0.1
(-0.4235%)
Market Closed
35,682.00
حجم التداول
-2.935
الربح لكل سهم
-
العائد الربحي
-8.163194
P/E
1,643,989,459.42
حجم السوق
اليوم
-0.4235%
1 اسبوع
1.249%
1 شهر
11.793%
6 اشهر
15.642%
12 اشهر
27.356%
بداية السنة
10.427%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Xencor

Sector:
Healthcare
Industry:
Biotechnology
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
هل تحتاج مساعدة او لديك استفسار؟